Xiaoling Yu

201 papers receiving 5.4k citations

Xiaoling Yu's Hit Papers

Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment 2017 · 325 citations
3250+3+6Years since publication100200300

Peers

Xiaoling Yu
Comparison fields: 5 of 93
  • Hepatology 2.6k
  • Critical Care and Intensive Care Medicine 125
  • Endocrinology, Diabetes and Metabolism 426
  • Biomedical Engineering 886
  • Pulmonary and Respiratory Medicine 690
Replace Fangyi Liu with:
Fangyi Liu China
Zhigang Cheng China
Frédèric Deschamps France
Xiao-yan Xie China
Wen‐Ping Wang China
Hui‐Xiong Xu China
Ming‐De Lu China
Andrej P. Lyshchik United States
David Lu United States
Alice R. Gillams United Kingdom
Xiaoling Yu relative to Fangyi Liu China Fangyi Liu's profile →
Citations per field
00.5×2×2.6×
Fangyi Liu · 1×
Citations per year

Countries citing papers authored by Xiaoling Yu

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Yu more than expected).

Fields of papers citing papers by Xiaoling Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Yu. The network helps show where Xiaoling Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoling Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoling Yu Line = papers co-authored together Xiaoling Yu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 213 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Hit paper breakdown →
2017325
2 2009300
3 2005198
4 2003189
5 2010161
6 2016149
7 2012134
8 2008114
9 1998106
10 2017102
11 202095
12 200188
13 201188
14 201487
15 202286
16 200381
17 201281
18 201977
19 201375
20 201173

About Xiaoling Yu

Xiaoling Yu is a scholar working on Hepatology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Biomedical Engineering, having authored 213 papers that have together received 5.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (110 papers), Renal cell carcinoma treatment (27 papers), Ultrasound and Hyperthermia Applications (16 papers), Ultrasound Imaging and Elastography (11 papers), Thyroid Cancer Diagnosis and Treatment (11 papers), Thyroid and Parathyroid Surgery (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Ultrasound in Clinical Applications (6 papers). The work is most often cited by research in Hepatology (2.6k citations), Critical Care and Intensive Care Medicine (125 citations), Endocrinology, Diabetes and Metabolism (426 citations), Biomedical Engineering (886 citations) and Pulmonary and Respiratory Medicine (690 citations). Xiaoling Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ping Liang, Zhigang Cheng, Jie Yu, Fangyi Liu, Baowei Dong, Zhiyu Han, Zhiyu Han, Dejiang Yu, Jie Tian and Wenting Shang. Their work appears in journals such as International Journal of Hyperthermia, European Journal of Radiology, European Radiology, Ultrasound in Medicine & Biology and Abdominal Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact